TLP
Trinity Legacy Partners’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,224
| Closed | -$218K | – | 95 |
|
2024
Q4 | $218K | Hold |
1,224
| – | – | 0.06% | 89 |
|
2024
Q3 | $239K | Hold |
1,224
| – | – | 0.06% | 91 |
|
2024
Q2 | $210K | Hold |
1,224
| – | – | 0.06% | 97 |
|
2024
Q1 | $223K | Sell |
1,224
-935
| -43% | -$170K | 0.07% | 98 |
|
2023
Q4 | $335K | Sell |
2,159
-35
| -2% | -$5.42K | 0.11% | 85 |
|
2023
Q3 | $327K | Sell |
2,194
-27,123
| -93% | -$4.04M | 0.11% | 81 |
|
2023
Q2 | $3.95M | Buy |
29,317
+283
| +1% | +$38.1K | 1.38% | 32 |
|
2023
Q1 | $4.63M | Buy |
29,034
+980
| +3% | +$156K | 1.74% | 22 |
|
2022
Q4 | $4.53M | Sell |
28,054
-2
| -0% | -$323 | 1.81% | 24 |
|
2022
Q3 | $3.77M | Sell |
28,056
-2,262
| -7% | -$304K | 1.61% | 25 |
|
2022
Q2 | $4.65M | Sell |
30,318
-3,265
| -10% | -$500K | 1.81% | 20 |
|
2022
Q1 | $5.44M | Buy |
33,583
+783
| +2% | +$127K | 1.84% | 19 |
|
2021
Q4 | $4.44M | Buy |
32,800
+1,606
| +5% | +$217K | 1.51% | 22 |
|
2021
Q3 | $3.37M | Buy |
31,194
+1,502
| +5% | +$162K | 1.21% | 30 |
|
2021
Q2 | $3.5M | Buy |
29,692
+2,485
| +9% | +$293K | 1.29% | 27 |
|
2021
Q1 | $2.94M | Buy |
27,207
+6,510
| +31% | +$703K | 1.17% | 30 |
|
2020
Q4 | $2.22M | Sell |
20,697
-2,002
| -9% | -$215K | 1.01% | 32 |
|
2020
Q3 | $1.99M | Buy |
22,699
+660
| +3% | +$58K | 0.96% | 28 |
|
2020
Q2 | $2.18M | Buy |
22,039
+12,487
| +131% | +$1.24M | 1.12% | 27 |
|
2020
Q1 | $718K | Buy |
9,552
+1,262
| +15% | +$94.9K | 0.51% | 38 |
|
2019
Q4 | $748K | Buy |
8,290
+5,155
| +164% | +$465K | 0.35% | 43 |
|
2019
Q3 | $231K | Buy |
+3,135
| New | +$231K | 0.11% | 57 |
|